By Economic Times
Neuralink, Elon Musk‘s brain-computer interface company, has now received the go ahead from US Food and Drug Administration (FDA) to begin testing its first-in-human clinical tests.
With the FDA approval out of the way, Musk’s Neuralink can now implant actual humans in their heads with Neuralink device.
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study,” Neuralink tweeted.
“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” it added.
On receiving the FDA approval, Musk also tweeted congratulating the Neuralink team.
But Musk and his team at Neuralink aren’t the only ones who will be spending their weekends in a celebration mode. The news also stunned microblogging platform Twitter, which couldn’t help but draw a comparison between Neuralink’s brain chip tech advancement and ChatBot led by artificial intelligence.
